The phosphodiesterase 4 inhibitor roflumilast is effective in the treatment of allergic rhinitis

Background: The beneficial effects of phosphodiesterase 4 (PDE4) inhibitors in allergic asthma have been shown in previous preclinical and clinical studies. Because allergic rhinitis and asthma share several epidemiologic and pathophysiologic factors, PDE4 inhibitors might also be effective in aller...

Full description

Saved in:
Bibliographic Details
Main Authors: Schmidt, Bernhard (Author) , Kusma, Matthias (Author) , Feuring, Martin (Author) , Timmer, Wolfgang E. (Author) , Neuhäuser, Markus (Author) , Bethke, Thomas (Author) , Stuck, Boris (Author) , Hörmann, Karl (Author) , Wehling, Martin (Author)
Format: Article (Journal)
Language:English
Published: 2001
In: The journal of allergy and clinical immunology
Year: 2001, Volume: 108, Issue: 4, Pages: 530-536
ISSN:1097-6825
DOI:10.1067/mai.2001.118596
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1067/mai.2001.118596
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0091674901145112
Get full text
Author Notes:Bernhard M. W. Schmidt, Matthias Kusma, Martin Feuring, Wolfgang E. Timmer, Markus Neuhäuser, Thomas Bethke, Boris A. Stuck, Karl Hörmann, Martin Wehling

MARC

LEADER 00000caa a2200000 c 4500
001 1813086370
003 DE-627
005 20230427070239.0
007 cr uuu---uuuuu
008 220803s2001 xx |||||o 00| ||eng c
024 7 |a 10.1067/mai.2001.118596  |2 doi 
035 |a (DE-627)1813086370 
035 |a (DE-599)KXP1813086370 
035 |a (OCoLC)1341464787 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Schmidt, Bernhard  |e VerfasserIn  |0 (DE-588)1023533162  |0 (DE-627)717961656  |0 (DE-576)366938045  |4 aut 
245 1 4 |a The phosphodiesterase 4 inhibitor roflumilast is effective in the treatment of allergic rhinitis  |c Bernhard M. W. Schmidt, Matthias Kusma, Martin Feuring, Wolfgang E. Timmer, Markus Neuhäuser, Thomas Bethke, Boris A. Stuck, Karl Hörmann, Martin Wehling 
264 1 |c 2001 
300 |a 7 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Elektronische Reproduktion der Druck-Ausgabe vom 25 Mai 2002 
500 |a Gesehen am 03.08.2022 
520 |a Background: The beneficial effects of phosphodiesterase 4 (PDE4) inhibitors in allergic asthma have been shown in previous preclinical and clinical studies. Because allergic rhinitis and asthma share several epidemiologic and pathophysiologic factors, PDE4 inhibitors might also be effective in allergic rhinitis. Objective: The main objective of this study was to investigate the efficacy of oral roflumilast (500 μg/day) in allergic rhinitis. Methods: In a randomized, placebo-controlled, double-blinded, crossover study, 25 subjects (16 male, 9 female; median age, 28 years) with histories of allergic rhinitis but asymptomatic at screening received roflumilast (500 μg once daily) and placebo for 9 days each with a washout period of at least 14 days in between treatment periods. In each of the treatment periods, controlled intranasal allergen provocation with pollen extracts was performed daily beginning the third day of treatment, each time approximately 2 hours after study drug administration. Five and 30 minutes after each allergen provocation, rhinal airflow was measured by means of anterior rhinomanometry and the subjective symptoms obstruction, itching, and rhinorrhea were assessed by means of a standardized visual analog scale. Results: Rhinal airflow improved almost consistently during the 9 days of roflumilast treatment, and it was significantly higher at study day 9 on roflumilast in comparison with placebo, a result also found for itching and rhinorrhea. With respect to the subjective obstruction score, a significant difference in comparison with placebo could be demonstrated within 4 days. Conclusion: This study shows that a PDE4 inhibitor, roflumilast, effectively controls symptoms of allergic rhinitis. Thus PDE4 inhibitors might be a future treatment option not only in allergic asthma but also in allergic rhinitis or the combination of the 2 diseases. (J Allergy Clin Immunol 2001;108:530-6.) 
650 4 |a Allergic rhinitis 
650 4 |a asthma 
650 4 |a PDE4 inhibitors 
650 4 |a rhinomanometry 
700 1 |a Kusma, Matthias  |d 1973-  |e VerfasserIn  |0 (DE-588)124274366  |0 (DE-627)70659231X  |0 (DE-576)294097384  |4 aut 
700 1 |a Feuring, Martin  |d 1963-2018  |e VerfasserIn  |0 (DE-588)1075744083  |0 (DE-627)833665383  |0 (DE-576)176498125  |4 aut 
700 1 |a Timmer, Wolfgang E.  |e VerfasserIn  |4 aut 
700 1 |a Neuhäuser, Markus  |e VerfasserIn  |4 aut 
700 1 |a Bethke, Thomas  |e VerfasserIn  |4 aut 
700 1 |a Stuck, Boris  |d 1972-  |e VerfasserIn  |0 (DE-588)121842371  |0 (DE-627)081570260  |0 (DE-576)182279111  |4 aut 
700 1 |a Hörmann, Karl  |d 1948-  |e VerfasserIn  |0 (DE-588)130123749  |0 (DE-627)49171193X  |0 (DE-576)266607438  |4 aut 
700 1 |a Wehling, Martin  |d 1957-  |e VerfasserIn  |0 (DE-588)129939331  |0 (DE-627)484463152  |0 (DE-576)297912577  |4 aut 
773 0 8 |i Enthalten in  |t The journal of allergy and clinical immunology  |d Amsterdam [u.a.] : Elsevier, 1971  |g 108(2001), 4, Seite 530-536  |h Online-Ressource  |w (DE-627)32045553X  |w (DE-600)2006613-2  |w (DE-576)094478864  |x 1097-6825  |7 nnas  |a The phosphodiesterase 4 inhibitor roflumilast is effective in the treatment of allergic rhinitis 
773 1 8 |g volume:108  |g year:2001  |g number:4  |g pages:530-536  |g extent:7  |a The phosphodiesterase 4 inhibitor roflumilast is effective in the treatment of allergic rhinitis 
856 4 0 |u https://doi.org/10.1067/mai.2001.118596  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0091674901145112  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220803 
994 |a 2001 
998 |g 129939331  |a Wehling, Martin  |m 129939331:Wehling, Martin  |d 60000  |d 65400  |e 60000PW129939331  |e 65400PW129939331  |k 0/60000/  |k 1/60000/65400/  |p 9  |y j 
998 |g 130123749  |a Hörmann, Karl  |m 130123749:Hörmann, Karl  |d 60000  |d 62100  |e 60000PH130123749  |e 62100PH130123749  |k 0/60000/  |k 1/60000/62100/  |p 8 
998 |g 121842371  |a Stuck, Boris  |m 121842371:Stuck, Boris  |d 60000  |d 62100  |e 60000PS121842371  |e 62100PS121842371  |k 0/60000/  |k 1/60000/62100/  |p 7 
998 |g 1075744083  |a Feuring, Martin  |m 1075744083:Feuring, Martin  |d 60000  |d 65400  |e 60000PF1075744083  |e 65400PF1075744083  |k 0/60000/  |k 1/60000/65400/  |p 3 
998 |g 124274366  |a Kusma, Matthias  |m 124274366:Kusma, Matthias  |d 60000  |d 65400  |e 60000PK124274366  |e 65400PK124274366  |k 0/60000/  |k 1/60000/65400/  |p 2 
998 |g 1023533162  |a Schmidt, Bernhard  |m 1023533162:Schmidt, Bernhard  |d 60000  |d 65400  |e 60000PS1023533162  |e 65400PS1023533162  |k 0/60000/  |k 1/60000/65400/  |p 1  |x j 
999 |a KXP-PPN1813086370  |e 4175564152 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"note":["Elektronische Reproduktion der Druck-Ausgabe vom 25 Mai 2002","Gesehen am 03.08.2022"],"title":[{"title_sort":"phosphodiesterase 4 inhibitor roflumilast is effective in the treatment of allergic rhinitis","title":"The phosphodiesterase 4 inhibitor roflumilast is effective in the treatment of allergic rhinitis"}],"origin":[{"dateIssuedKey":"2001","dateIssuedDisp":"2001"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"family":"Schmidt","display":"Schmidt, Bernhard","role":"aut","given":"Bernhard"},{"given":"Matthias","role":"aut","family":"Kusma","display":"Kusma, Matthias"},{"role":"aut","given":"Martin","display":"Feuring, Martin","family":"Feuring"},{"role":"aut","given":"Wolfgang E.","display":"Timmer, Wolfgang E.","family":"Timmer"},{"family":"Neuhäuser","display":"Neuhäuser, Markus","given":"Markus","role":"aut"},{"given":"Thomas","role":"aut","display":"Bethke, Thomas","family":"Bethke"},{"given":"Boris","role":"aut","display":"Stuck, Boris","family":"Stuck"},{"family":"Hörmann","display":"Hörmann, Karl","given":"Karl","role":"aut"},{"role":"aut","given":"Martin","display":"Wehling, Martin","family":"Wehling"}],"relHost":[{"disp":"The phosphodiesterase 4 inhibitor roflumilast is effective in the treatment of allergic rhinitisThe journal of allergy and clinical immunology","language":["eng"],"part":{"extent":"7","volume":"108","year":"2001","pages":"530-536","text":"108(2001), 4, Seite 530-536","issue":"4"},"note":["Gesehen am 23.08.2021"],"title":[{"subtitle":"official publication of the American Academy of Allergy, Asthma and Immunology","title_sort":"journal of allergy and clinical immunology","title":"The journal of allergy and clinical immunology"}],"origin":[{"dateIssuedDisp":"1971-","publisherPlace":"Amsterdam [u.a.] ; St. Louis, Mo.","publisher":"Elsevier ; Mosby","dateIssuedKey":"1971"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"32045553X","pubHistory":["47.1971 -"],"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1097-6825"],"eki":["32045553X"],"zdb":["2006613-2"]}}],"id":{"doi":["10.1067/mai.2001.118596"],"eki":["1813086370"]},"recId":"1813086370","name":{"displayForm":["Bernhard M. W. Schmidt, Matthias Kusma, Martin Feuring, Wolfgang E. Timmer, Markus Neuhäuser, Thomas Bethke, Boris A. Stuck, Karl Hörmann, Martin Wehling"]},"physDesc":[{"extent":"7 S."}]} 
SRT |a SCHMIDTBERPHOSPHODIE2001